دانلود مقاله ISI انگلیسی شماره 121137
ترجمه فارسی عنوان مقاله

خواص روان سنجی سه معیار ارزیابی نظریه پیشرفته ذهن: شواهد از افراد مبتلا به اسکیزوفرنیا

عنوان انگلیسی
Psychometric properties of three measures assessing advanced theory of mind: Evidence from people with schizophrenia
کد مقاله سال انتشار تعداد صفحات مقاله انگلیسی
121137 2017 7 صفحه PDF
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : Psychiatry Research, Volume 257, November 2017, Pages 490-496

ترجمه کلمات کلیدی
تئوری پیشرفته ذهن، جنون جوانی، خواص روان سنجی،
کلمات کلیدی انگلیسی
Advanced theory of mind; Schizophrenia; Psychometric properties;
پیش نمایش مقاله
پیش نمایش مقاله  خواص روان سنجی سه معیار ارزیابی نظریه پیشرفته ذهن: شواهد از افراد مبتلا به اسکیزوفرنیا

چکیده انگلیسی

Patients with schizophrenia tend to have deficits in advanced Theory of Mind (ToM). The “Reading the mind in the eyes” test (RMET), the Faux Pas Task, and the Strange Stories are commonly used for assessing advanced ToM. However, most of the psychometric properties of these 3 measures in patients with schizophrenia are unknown. The aims of this study were to validate the psychometric properties of the 3 advanced ToM measures in patients with schizophrenia, including: (1) test-retest reliability; (2) random measurement error; (3) practice effect; (4) concurrent validity; and (5) ecological validity. We recruited 53 patients with schizophrenia, who completed the 3 measures twice, 4 weeks apart. The Revised Social Functioning Scale-Taiwan short version (R-SFST) was completed within 3 days of first session of assessments. We found that the intraclass correlation coefficients of the RMET, Strange Stories, and Faux Pas Task were 0.24, 0.5, and 0.76. All 3 advanced ToM measures had large random measurement error, trivial to small practice effects, poor concurrent validity, and low ecological validity. We recommend that the scores of the 3 advanced ToM measures be interpreted with caution because these measures may not provide reliable and valid results on patients’ advanced ToM abilities.